Skip to main navigation Skip to search Skip to main content

InSe Nanosheets for Efficient NIR-II-Responsive Drug Release

  • Chi Huang
  • , Zhengbo Sun
  • , Haodong Cui
  • , Ting Pan
  • , Shengyong Geng
  • , Wenhua Zhou*
  • , Paul K. Chu
  • , Xue-Feng Yu*
  • *Corresponding author for this work

Research output: Journal Publications and ReviewsRGC 21 - Publication in refereed journalpeer-review

Abstract

Near-infrared-II (NIR-II) biowindow is appealing from the perspectives of larger maximum permissible exposure in comparison with the near-infrared-I biowindow, so the NIR-II-responsive drug-delivery nanoplatform is highly desirable. In this work, two-dimensional InSe nanosheets (InSe NSs) are modified with poly(ethylene glycol) and evaluated as an effective NIR-II-responsive cancer treatment nanoplatform. The InSe NSs synthesized by liquid exfoliation exhibit prominent NIR-II-responsive photothermal conversion efficiency (39.5%) and photothermal stability. Moreover, the InSe NSs have a doxorubicin (DOX) loading capacity as high as 93.6%, along with excellent NIR-II-responsive DOX release characteristic. The superior synergistic chemo/photothermal effects have also been demonstrated by the in vitro experiments in killing cancer cells. In combination with good biocompatibility, the InSe NSs have great potential in therapeutic applications.
Original languageEnglish
Pages (from-to)27521−27528
JournalACS Applied Materials and Interfaces
Volume11
Issue number31
Online published10 Jun 2019
DOIs
Publication statusPublished - 7 Aug 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Keywords

  • cancer treatment
  • drug release
  • InSe
  • NIR-II
  • two-dimensional nanomaterials

Fingerprint

Dive into the research topics of 'InSe Nanosheets for Efficient NIR-II-Responsive Drug Release'. Together they form a unique fingerprint.

Cite this